查詢結果分析
相關文獻
- 以免疫吸附血漿析離療法治療重症肌無力症之評估
- 重症肌無力症之免疫吸附血漿析離療法:免疫吸附管之吸附性能研究
- Experience in the Treatment of Myasthenia Gravis with Double Filtration Plasmapheresis
- 重症肌無力症之血漿析離療法
- 雙重過濾血漿析離術過濾效能之比較--Kuraray KM8800及Asahi Plasauto iQ
- 血漿析離療法引起之凝血異常:一例報告
- 雙重過濾血漿析離療法之血液學變化--每日及隔日療法之比較
- 雙重過濾血漿析離療法之血管通路研究--雙腔導管及周邊靜脈之比較
- 手術後嚴重黃疸之選擇性膽紅素吸附血漿灌流療法:一例報告
- 多發性硬化症之血液析離療法
頁籤選單縮合
題名 | Experience in the Treatment of Myasthenia Gravis with Double Filtration Plasmapheresis=以雙重過濾血漿析離術治療重症肌無力之經驗 |
---|---|
作者 | 莊瑤程; 李建德; 陳靖博; 徐崇瑛; Chuang, Yao-cheng; Lee, Chien-te; Chen, Jin-bor; Chee, Esther Chung-yin; |
期刊 | 長庚醫學 |
出版日期 | 20000200 |
卷期 | 23:2 2000.02[民89.02] |
頁次 | 頁80-86 |
分類號 | 415.9413 |
語文 | eng |
關鍵詞 | 重症肌無力; 血漿析離術; 雙重過濾血漿析離術; Myasthenia gravis; Plasmapheresis; Double filtration plasmapheresis; |
英文摘要 | Background. Myasthenia gravis (MG) is an autoimmune disease characterized by production of autoantibodies directly against acetylcholine receptors on postjunctional membranes. The treatment modalities of myasthenia gravis include cholinesterase inhibitors, surgical thymectomy, immunosuppressive treatment, and short-term immunotherapies, including plasmapheresis and intravenous immune globulin. Double filtration plasmapheresis (DFP) is a new technique of plasmapheresis. The aim of our study is to evaluate the effectiveness and complications of DFP in the treatment of MG. Methods. From December, 1993 to August, 1998, a total of 33 patients with MG received 68 courses (total of 299 sessions) of DFP in our hospital. Plasmapheresis volume, drainage volume, treatment duration, heparin dose, and complications were recorded. In addition, clinical responses after DFP were also evaluated. Results. Only 4 courses (5.88%) of treatment were ineffective. Sixty-four courses (94.12%) of treatment lessened disease activity. The complications of DFP included 15 episodes of hypotension (5.01%), 2 of bradycardia (0.67%), 3 of chest pain (1.00%), 7 of dizziness (2.34%), 58 of high transmembranous pressure of plasma separator (19.40%), 3 of high secondary pressure of plasma fractionator (1.00%), 12 of hemo-lysis (4.01%), 2 of plasma separator clot (0.67%), 2 of plasma fractionator clot (0.67%), 3 of blood leakage (1.00%), and 1 of air embolism (0.33%). There was no mortality associated with the DFP procedure. Conclusion. DFP is a safe, convenient, and time-saving therapy with rare severe complications in the treatment of MG. Our experience confirms its effectiveness when used in combination with drug therapy and thymectomy. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。